Details
Stereochemistry | EPIMERIC |
Molecular Formula | C32H47F5O3S |
Molecular Weight | 606.771 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]3([H])C4=C(C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@@]23[H])C=C(O)C=C4
InChI
InChIKey=VWUXBMIQPBEWFH-WCCTWKNTSA-N
InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1
Molecular Formula | C32H47F5O3S |
Molecular Weight | 606.771 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:51:42 UTC 2023
by
admin
on
Fri Dec 15 15:51:42 UTC 2023
|
Record UNII |
22X328QOC4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QL02BA03
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
||
|
LIVERTOX |
NBK548072
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
||
|
NDF-RT |
N0000175582
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
||
|
NCI_THESAURUS |
C2116
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
||
|
NDF-RT |
N0000000168
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
||
|
WHO-ATC |
L02BA03
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
||
|
NDF-RT |
N0000175826
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
FASLODEX (AUTHORIZED: BREAST NEOPLASMS)
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7658
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
N0000000145
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | Estrogen Receptor Antagonists [MoA] | ||
|
1255
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
DB00947
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
22X328QOC4
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
282357
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | RxNorm | ||
|
759879
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
C1379
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
22X328QOC4
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
100000089504
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
7712
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
KK-128
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
31638
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
129453-61-8
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
SUB13933MIG
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
FULVESTRANT
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
104741
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
1286650
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
1015
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
m5583
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL1358
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
DTXSID4022369
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY | |||
|
C070081
Created by
admin on Fri Dec 15 15:51:42 UTC 2023 , Edited by admin on Fri Dec 15 15:51:42 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
Selective estrogen receptor degrader (SERD)
BINDING
IC50
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
Binding assay
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
CELL->INHIBITOR |
Viablity
IC50
|
||
|
TARGET->DEGRADER, SELECTIVE |
100% Degradation as control
EC50
|
||
|
TARGET->DEGRADER, SELECTIVE |
Selective estrogen receptor degrader (SERD)
BINDING
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
PARENT -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||